Literature DB >> 23664429

[Mexican consensus on portal hypertension].

R M Narváez-Rivera1, C A Cortez-Hernández, J A González-González, J L Tamayo-de la Cuesta, F Zamarripa-Dorsey, A Torre-Delgadillo, J F J Rivera-Ramos, J I Vinageras-Barroso, J E Muneta-Kishigami, J M Blancas-Valencia, M Antonio-Manrique, F Valdovinos-Andraca, P Brito-Lugo, A Hernández-Guerrero, R Bernal-Reyes, S Sobrino-Cossío, G R Aceves-Tavares, H M Huerta-Guerrero, N Moreno-Gómez, F J Bosques-Padilla.   

Abstract

The aim of the Mexican Consensus on Portal Hypertension was to develop documented guidelines to facilitate clinical practice when dealing with key events of the patient presenting with portal hypertension and variceal bleeding. The panel of experts was made up of Mexican gastroenterologists, hepatologists, and endoscopists, all distinguished professionals. The document analyzes themes of interest in the following modules: preprimary and primary prophylaxis, acute variceal hemorrhage, and secondary prophylaxis. The management of variceal bleeding has improved considerably in recent years. Current information indicates that the general management of the cirrhotic patient presenting with variceal bleeding should be carried out by a multidisciplinary team, with such an approach playing a major role in the final outcome. The combination of drug and endoscopic therapies is recommended for initial management; vasoactive drugs should be started as soon as variceal bleeding is suspected and maintained for 5 days. After the patient is stabilized, urgent diagnostic endoscopy should be carried out by a qualified endoscopist, who then performs the corresponding endoscopic variceal treatment. Antibiotic prophylaxis should be regarded as an integral part of treatment, started upon hospital admittance and continued for 5 days. If there is treatment failure, rescue therapies should be carried out immediately, taking into account that interventional radiology therapies are very effective in controlling refractory variceal bleeding. These guidelines have been developed for the purpose of achieving greater clinical efficacy and are based on the best evidence of portal hypertension that is presently available.
Copyright © 2012 Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23664429     DOI: 10.1016/j.rgmx.2013.01.006

Source DB:  PubMed          Journal:  Rev Gastroenterol Mex        ISSN: 0375-0906


  1 in total

1.  Study of the association between hemorrhage and the position of hemorrhagic stigmata in patients with esophageal varices.

Authors:  Shao-Hua Shen; Ying-Di Liu; Xiao Sun; Meng Li; Guo-Hui Sun; Juan Wang; Jiang-Tao Liu; Jun Tie; Jing Yang
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.